# ApcinteX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apcintex

- Industry: Pharmaceuticals
- Headquarters: Cambridge, UK
- Total disclosed funding: $18M
- Latest round: Series A (Dec 7, 2016)
- Investors on record: 3

## About

Established in 2014 and based in Cambridge, UK, ApcinteX Limited operates as a developer of therapeutics for hemophilia treatment.

## Funding rounds

- Series A, Dec 7, 2016, $18M — Cambridge Enterprise, Touchstone Innovations, Medicxi

## Investors

- Cambridge Enterprise — Series A
- Touchstone Innovations (https://capitalatlas.ai/funds/touchstone-innovations) — Series A
- Medicxi (https://capitalatlas.ai/funds/medicxi) — Series A